Nanotechnology has the potential to satisfy these requirements if some of its intrinsic shortcomings can be solved: rapid uptake of
nanocarriers by RES and the toxicity as a result, and drug release outside the tumor, especially the early burst release when the fast drug release is coupled with high blood... more»
Not exact matches
Now, a multidisciplinary research team led
by David Eckmann, MD, PhD, Horatio C. Wood Professor of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania and professor of Bioengineering in Penn's School of Engineering and Applied Science, has found that when delivered
by a microscopic transporter called a
nanocarrier, steroids can access the hard - to - reach lung endothelial cells that need it most and are successful at preventing inflammation in mice.
Enhanced endothelial delivery and biochemical effects of α - galactosidase
by ICAM -1-targeted
nanocarriers for Fabry disease.
Enhanced delivery of α - glucosidase for Pompe disease
by ICAM -1-targeted
nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders.
Targeting, Endocytosis, and Lysosomal Delivery of Active Enzymes to Model Human Neurons
by ICAM -1-Targeted
Nanocarriers.
Investigation of Strategies for Drug Delivery
by Combination Targeting of
Nanocarriers to Multiple Epitopes or Receptors.
«These
nanocarriers developed
by our team have a variety of applications in medication and as a gene transfection agent for biological research,» said Dr Yi - Yan Yang, who led the project team comprising Yong Wang, Shujun Gao, Wen - Hui Ye and Ho Sup Yoon.